A new class of drugs, known as SGLT2 inhibitors, is more frequently being prescribed for the treatment of type 2 diabetes, but may increase the risk of a serious complication known as diabetic ketoacidosis, according to new research In a study published in the New England Journal of Medicine, investigators from Brigham and Women’s Hospital… Continue reading Diabetes Drug Linked to Serious Complication